Two-new-leaders-for-ANZCA-and-FPM-11-May-2018
Interventional_Pain_Medicine
Final Report form ANZCA Grants
Final report form for ANZCA grants
Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
Tasmanian Health 22072002
ANZCA-response-to-ANZCOR-guideline-4-Airway-20210127
Tasmanian Health Service NWRH April 2021
ANZCA-response-to-TGA-repurposing-medicines-consultation-20210330
DRGA-Media-Release-290921